Ascendas REIT – Worth the price tag July 27, 2020 1263

PSR Recommendation: ACCUMULATE Status: Maintained
Last Close Price: S$2.74 Target Price: S$3.630
  • 1H20 DPU of 7.27 cents formed 44.4% of our FY20e DPU.
  • Positive rental reversions of 4.3% for 2Q20 amidst a more cautious leasing backdrop.
  • Diversified and stable portfolio, with out-of-pocket rebates totaling c.2% of FY20e revenue. Well-positioned for acquisition – low cost of borrowing maintained and P/NAV at a premium (1.6x).
  • Maintain ACCUMULATE with a higher TP of S$3.63 (prev. $3.29) mainly due to a lower beta assumption, which lowered our cost of equity from 6.45% to 6.0%. We adjust our estimates to reflect the acquisition of the 25% stake in Galaxis and the acquisition of the Australian logistic asset at Kiora Crescent.

 

Positives

+ Achieved positive portfolio rental reversions of +4.3%/+5.4% for 2Q/1H20. Portfolio reversions for 1Q20 came in at +8.0%. In Singapore, average rental reversion was +4.0% – business parks clocked +16.3% reversions due to certain assets in Changi Business Park; one renewal was by an international bank whose rent were marked-to-market upon renewal. Integrated Development penciled a 19.8% reversion due to Aperia while industrial and flatted factories achieved +5.1% reversions. -30.6% reversions for Hi-Spec asset class due to favourable rates offered to retain the tenant. Average rental reversion for Australia and the US were +16.6% and +16.2% respectively.

+ In it for the long haul – Forging ahead with acquisitions and AEIs. AREIT announced 2 acquisition YTD – acquisition of 25% stake in Galaxis was completed on 31 March 2020 at 3% discount to market value which the acquisition of a logistic asset under development (Kiora Crescent, Yennora, Sydney) was announced on 1 July 2020. During the quarter, AREIT completed 4 AEIs costing $22.9mn. In 2Q FY2020, S$16.3 million worth of new AEIs commenced across four properties.

+ Portfolio metrics remain healthy. Portfolio occupancy rate remained stable at 91.5% (1Q20: 91.7%), with improvements in Australia partially offsetting lower occupancies in SG and US. Aggregate leverage held steady at 36.1% (31 March 2020: 36.2%, 31 December 2019: 35.1%). Weighted average all-in cost of borrowing was maintained at 2.9% (31 March 2020: 2.9%, 31 December 2019: 2.9%)

 

Negatives

– 1H20 DPU fell -10.8% YoY due to larger unit base (+16.3%), rental waivers of $20mn and absence of rollover adjustments (1H19 +7.2mn).

 

Outlook

Rental rebates

Singapore (70% of AUM) – In line with the Singapore Government’s guidelines, AREIT has provided rent waivers to its tenants, amounting approximately S$20 million year-to-date. The actual amount to be disbursed will depend on the tenants’ eligibility assessment by the authorities. This amount is in addition to the Singapore Government’s property tax rebates and cash grants which will be fully passed through to eligible tenants. AREIT estimates that there are c.20% of SMEs in the portfolio.

 

Australia (13% of AUM) – Rent collection has been suspended from the F&B and retail tenants located at Ascendas Reit’s three suburban offices from April 2020 until their reopening. One lease of a leisure/hospitality tenant has been restructured and the tenant was provided with rent rebate. Rent waiver and deferment were offered to two small and medium enterprise (SME) tenants. The overall impact to AREIT is less than S$0.6 million.

 

United Kingdom (6% of AUM) – The rental payment frequency for some tenants has been changed from quarterly to monthly in advance and some rents have been deferred to the later part of the year to provide some cashflow relief to tenants.

 

United States (11% of AUM) – US$10,000 of rent rebates have been provided to date.

 

Maintain ACCUMULATE with and higher TP of S$3.62 (prev. $3.29)

We adjust our estimates to reflect the acquisition of the 25% stake in Galaxis and the acquisition of the Australian logistic asset at Kiora Crescent. Our TP is raised to $3.62 mainly due to a lower beta assumption, which lowered our cost of equity from 6.45% to 6.0%. We expect FY20e DPU yield of 4.8% at current entry price.

We see the merits of AREIT’s S$12.75 bn portfolio comprising of 197 properties spanning across Singapore, Australia, UK and the US, which results in low asset concentration risk (no property accounts for more than 4.6% of revenue). AREIT’s geographically diversified portfolio and low tenant concentration risk (1,490 tenants, the largest tenant accounts for <4% of revenue) also helps to reduce the impact to the portfolio. Arrears for 1Q20 was below 1%, largely in line with historical numbers. Distribution visibility remains high – management does not think that they will need to retain distributions due to AREIT’s strong cash position S$561 million comprising of S$361 million in cash and S$200 million in committed facilities) to meet cashflow needs.

Despite its P/NAV of 1.6x which is on the high side, we think AREIT’s stability is due to tenant and geographical diversification and track record of DPU accretive acquisitions and AEIs justifies its premium. We think that AREIT’s low cost of borrowing (2.9%) and P/NAV which is at a premium presents a conducive environment for more acquisition.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!